While a relatively small sum of revenue it does bode well for the company. It's not often you find a biotech with a decent opportunity for a revenue stream to supplement the big potential payoff.
Curious as to wiser heads' views on the revenue potential for PIQ's analytical services business?
Ann: Proteomics secures major analytical services contract, page-2
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PIQ (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
74.0¢ |
Change
0.030(4.23%) |
Mkt cap ! $93.01M | |||
| Open | High | Low | Value | Volume |
| 71.0¢ | 74.0¢ | 71.0¢ | $69.86K | 96.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 14818 | 73.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 75.0¢ | 109350 | 3 |
View Market Depth
| Last trade - 15.06pm 13/11/2024 (20 minute delay) ? |
| PIQ (ASX) Chart |